XML 48 R32.htm IDEA: XBRL DOCUMENT v3.24.1
Stock-Based Compensation Plans (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Stock compensation expense

The Company recorded the following Stock compensation expense in its consolidated statements of income (in thousands):

 

                         
    Years Ended December 31,
    2023   2022   2021
Stock option grants   $ 60       69       69  
Restricted stock awards     1,028       800       492  
Employee stock grant     50       50       50  
Annual director stock award     600       650       500  
Stock compensation   $ 1,738       1,569       1,111  
Summary of changes in outstanding options

A Summary of changes in outstanding options is presented below (in thousands, except share and per share amounts):

 

      Weighted   Weighted   Weighted
  Number   Average   Average   Average
  of   Exercise   Remaining   Grant Date
Options Shares   Price   Term (yrs)   Fair Value(000's)
Outstanding at                              
  January 1, 2021   120,089     $ 35.33       5.3     $ 1,531  
    Exercised   (15,334 )   $ 17.54             $ (115 )
Outstanding at                              
  December 31, 2021   104,755     $ 37.93       4.8     $ 1,416  
    Exercised   (16,460 )   $ 25.07             $ (145 )
Outstanding at                              
  December 31, 2022   88,295     $ 40.33       4.4     $ 1,271  
    Exercised   (24,855 )   $ 41.21             $ (290 )
Outstanding at                              
  December 31, 2023   63,440     $ 39.99       3.5     $ 981  
Exercisable at                              
  December 31, 2023   63,440     $ 39.99       3.5     $ 981  
Vested during                              
  twelve months ended                              
  December 31, 2023   3,990                     $ 65  
Stock options outstanding

The following table summarizes information concerning Stock options outstanding at December 31, 2023:

 

        Shares      Weighted     Weighted  
Range of Exercise       under     Average     Average  
Prices per Share       Option     Exercise Price   Remaining Life
Exercisable:                            
$26.96 - $33.70       15,630         28.95       1.4  
$33.70 - $42.13       12,000         38.45       3.0  
$42.13 - $45.97       35,810         45.32       4.5  
Total       63,440       $ 39.99       3.5  Years
Changes in restricted stock awards

A summary of Changes in restricted stock awards is presented below (in thousands, except share and per share amounts):

 

 

        Weighted   Weighted   Weighted
    Number   Average   Average   Average
    Of   Exercise   Remaining   Grant Date
Restricted stock   Shares   Price   Term (yrs)   Fair Value(000's)
                 
Non-vested at January 1, 2021     20,520     $ 46.30     3.4   $ 950  
    Time-based awards granted     8,896       45.55           405  
    Performance-based awards granted     18,882       45.55           860  
    Vested     (2,224 )     45.55           (101 )
Non-vested at December 31, 2021     46,074     $ 45.88     3.1   $ 2,114  
    Time-based awards granted     7,448       57.80           431  
    Performance-based awards granted     14,016       57.80           810  
    Vested     (15,679 )     47.56           (746 )
    Forfeited     (1,363 )     46.30           (63 )
Non-vested at December 31, 2022     50,496     $ 50.42     3.0   $ 2,546  
    Time-based awards granted     7,980       53.86           430  
    Performance-based awards granted     17,304       53.92           933  
    Vested     (21,053 )     48.06           (1,012 )
Non-vested at December 31, 2023     54,727     $ 52.94     2.8   $ 2,897